Logo image of CMT

CORE MOLDING TECHNOLOGIES IN (CMT) Stock Fundamental Analysis

NYSEARCA:CMT - NYSE Arca - US2186831002 - Common Stock - Currency: USD

15.09  0 (0%)

After market: 15.5 +0.41 (+2.72%)

Fundamental Rating

7

Overall CMT gets a fundamental rating of 7 out of 10. We evaluated CMT against 85 industry peers in the Chemicals industry. CMT gets an excellent profitability rating and is at the same time showing great financial health properties. CMT may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make CMT suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CMT was profitable.
CMT had a positive operating cash flow in the past year.
In the past 5 years CMT has always been profitable.
In the past 5 years CMT always reported a positive cash flow from operatings.
CMT Yearly Net Income VS EBIT VS OCF VS FCFCMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

CMT has a better Return On Assets (6.35%) than 87.06% of its industry peers.
CMT has a better Return On Equity (9.02%) than 70.59% of its industry peers.
The Return On Invested Capital of CMT (7.49%) is better than 70.59% of its industry peers.
CMT had an Average Return On Invested Capital over the past 3 years of 9.78%. This is above the industry average of 7.13%.
Industry RankSector Rank
ROA 6.35%
ROE 9.02%
ROIC 7.49%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
CMT Yearly ROA, ROE, ROICCMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

With a decent Profit Margin value of 4.40%, CMT is doing good in the industry, outperforming 61.18% of the companies in the same industry.
In the last couple of years the Profit Margin of CMT has grown nicely.
With a Operating Margin value of 5.52%, CMT is not doing good in the industry: 62.35% of the companies in the same industry are doing better.
CMT's Operating Margin has improved in the last couple of years.
CMT has a Gross Margin of 17.61%. This is in the lower half of the industry: CMT underperforms 70.59% of its industry peers.
CMT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.52%
PM (TTM) 4.4%
GM 17.61%
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
CMT Yearly Profit, Operating, Gross MarginsCMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CMT is creating some value.
Compared to 1 year ago, CMT has less shares outstanding
CMT has more shares outstanding than it did 5 years ago.
CMT has a better debt/assets ratio than last year.
CMT Yearly Shares OutstandingCMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CMT Yearly Total Debt VS Total AssetsCMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

CMT has an Altman-Z score of 4.34. This indicates that CMT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.34, CMT belongs to the best of the industry, outperforming 89.41% of the companies in the same industry.
The Debt to FCF ratio of CMT is 0.91, which is an excellent value as it means it would take CMT, only 0.91 years of fcf income to pay off all of its debts.
CMT has a better Debt to FCF ratio (0.91) than 96.47% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that CMT is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.13, CMT belongs to the best of the industry, outperforming 83.53% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 0.91
Altman-Z 4.34
ROIC/WACC0.89
WACC8.4%
CMT Yearly LT Debt VS Equity VS FCFCMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.80 indicates that CMT has no problem at all paying its short term obligations.
CMT has a better Current ratio (2.80) than 82.35% of its industry peers.
CMT has a Quick Ratio of 2.30. This indicates that CMT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.30, CMT belongs to the best of the industry, outperforming 85.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.8
Quick Ratio 2.3
CMT Yearly Current Assets VS Current LiabilitesCMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

CMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.32%.
The Earnings Per Share has been growing by 40.08% on average over the past years. This is a very strong growth
CMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.87%.
CMT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.24% yearly.
EPS 1Y (TTM)-35.32%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-33.87%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-15.29%

3.2 Future

Based on estimates for the next years, CMT will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.57% on average per year.
CMT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.48% yearly.
EPS Next Y14.29%
EPS Next 2Y10.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.31%
Revenue Next 2Y1.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CMT Yearly Revenue VS EstimatesCMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CMT Yearly EPS VS EstimatesCMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2022 2023 2024 2025 2026 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.93 indicates a reasonable valuation of CMT.
Compared to the rest of the industry, the Price/Earnings ratio of CMT indicates a rather cheap valuation: CMT is cheaper than 85.88% of the companies listed in the same industry.
CMT is valuated cheaply when we compare the Price/Earnings ratio to 28.78, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.69, the valuation of CMT can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMT indicates a rather cheap valuation: CMT is cheaper than 83.53% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, CMT is valued rather cheaply.
Industry RankSector Rank
PE 9.93
Fwd PE 8.69
CMT Price Earnings VS Forward Price EarningsCMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CMT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CMT is cheaper than 95.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CMT is valued cheaply inside the industry as 92.94% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.91
EV/EBITDA 3.97
CMT Per share dataCMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CMT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y10.57%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CORE MOLDING TECHNOLOGIES IN

NYSEARCA:CMT (4/28/2025, 4:10:39 PM)

After market: 15.5 +0.41 (+2.72%)

15.09

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-11 2025-03-11/bmo
Earnings (Next)05-13 2025-05-13
Inst Owners68.22%
Inst Owner Change-0.88%
Ins Owners8.01%
Ins Owner Change3.37%
Market Cap139.73M
Analysts80
Price Target22.44 (48.71%)
Short Float %2.9%
Short Ratio6.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.51%
Min EPS beat(2)-100%
Max EPS beat(2)54.97%
EPS beat(4)3
Avg EPS beat(4)22.7%
Min EPS beat(4)-100%
Max EPS beat(4)72.09%
EPS beat(8)6
Avg EPS beat(8)73.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.12%
Min Revenue beat(2)0.98%
Max Revenue beat(2)5.25%
Revenue beat(4)3
Avg Revenue beat(4)4.35%
Min Revenue beat(4)-0.42%
Max Revenue beat(4)11.57%
Revenue beat(8)5
Avg Revenue beat(8)2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.16%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.59%
Revenue NY rev (1m)5.95%
Revenue NY rev (3m)5.95%
Valuation
Industry RankSector Rank
PE 9.93
Fwd PE 8.69
P/S 0.46
P/FCF 5.91
P/OCF 3.98
P/B 0.95
P/tB 1.11
EV/EBITDA 3.97
EPS(TTM)1.52
EY10.07%
EPS(NY)1.74
Fwd EY11.51%
FCF(TTM)2.55
FCFY16.91%
OCF(TTM)3.8
OCFY25.16%
SpS32.65
BVpS15.91
TBVpS13.56
PEG (NY)0.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.35%
ROE 9.02%
ROCE 9.66%
ROIC 7.49%
ROICexc 9.88%
ROICexgc 11.85%
OM 5.52%
PM (TTM) 4.4%
GM 17.61%
FCFM 7.81%
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
ROICexc(3y)11.4%
ROICexc(5y)9.43%
ROICexgc(3y)13.69%
ROICexgc(5y)11.53%
ROCE(3y)12.62%
ROCE(5y)10.78%
ROICexcg growth 3Y14.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y16.49%
ROICexc growth 5YN/A
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
F-Score6
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 0.91
Debt/EBITDA 0.65
Cap/Depr 86.01%
Cap/Sales 3.81%
Interest Coverage 15.55
Cash Conversion 116.8%
Profit Quality 177.65%
Current Ratio 2.8
Quick Ratio 2.3
Altman-Z 4.34
F-Score6
WACC8.4%
ROIC/WACC0.89
Cap/Depr(3y)98.69%
Cap/Depr(5y)85.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.23%
Profit Quality(3y)108.24%
Profit Quality(5y)132.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-35.32%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y14.29%
EPS Next 2Y10.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.87%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-15.29%
Revenue Next Year1.31%
Revenue Next 2Y1.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-51.76%
EBIT growth 3Y17.56%
EBIT growth 5YN/A
EBIT Next Year121.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.22%
FCF growth 3Y189.18%
FCF growth 5Y20.65%
OCF growth 1Y0.89%
OCF growth 3Y40.98%
OCF growth 5Y16.05%